Testimony Before U.S. Judicial Conference Advisory Committee on Appellate Rules

Amicus Strategy & Procedure, Atlantic Legal Foundation, Federal Courts of Appeals, Presentations /

On February 14, 2025 the U.S. Judicial Conference’s Advisory Committee on Appellate Rules heard testimony via Teams on proposed amendments to Federal Rule of Appellate Procedure 29.  The proposed amendments would (i) expand the funding-related disclosure requirements set forth in Rule 29(a)(4)(E), and (ii) eliminate the filing of court of appeals amicus briefs with the […]

Testimony Before U.S. Judicial Conference Advisory Committee on Appellate Rules Read More »

ALF Advocates Broad View of “Statutory Standing” To Challenge Federal Regulatory Actions

ALF Amicus Briefs, Federal Courts of Appeals, US Supreme Court /

The Supreme Court has granted certiorari in FDA v. R.J. Reynolds Vapor Co., No. 23-1187, to decide whether a federally regulated product’s manufacturer and retailers can join together, in a single federal court of appeals, to challenge a final agency action that impairs their shared commercial interests.  On behlaf of ALF, I have authored a merits-stage

ALF Advocates Broad View of “Statutory Standing” To Challenge Federal Regulatory Actions Read More »

ALF Again Argues That “Drug Price Negotiation Program” Is Unconstitutional

ALF Amicus Briefs, All Amicus Briefs, Atlantic Legal Foundation, Federal Courts of Appeals /

The Inflation Reduction Act’s highly politicized, misleadingly named, “Drug Price Negotiation Program,” 42 U.S.C. § 1320f et seq., is a form of government-imposed price control. Under the Program, the Centers for Medicare & Medicaid Services (CMS) selects certain “negotiation-eligible” brand-name drugs. Following a supposed “negotiation” and “agreement” with its manufacturer, each such drug can be sold within

ALF Again Argues That “Drug Price Negotiation Program” Is Unconstitutional Read More »

ALF Urges U.S. Judicial Conference To Reject Amicus Brief Rules Change

Amicus Strategy & Procedure, Atlantic Legal Foundation, Federal Courts of Appeals /

The U.S. Judicial Conference’s Advisory Committee on Appellate Rules has proposed amendments to Federal Rule of Appellate Procedure 29 that would hinder, rather than facilitate, the filing of amicus curiae (“friend of the court”) briefs in federal courts of appeals. Currently, Rule 29(a) permits organizations such as ALF to file a merits-stage amicus brief in a federal

ALF Urges U.S. Judicial Conference To Reject Amicus Brief Rules Change Read More »

Third Circuit Roundup® Ruling Is Roadmap For Preemption Of Failure-To-Warn Claims

All Publications, Commentary, Federal Courts of Appeals, Federal Preemption, Published Articles /

AT LAST! A federal court of appeals has correctly interpreted and applied the “parallel requirements” exception to federal preemption of pesticide-related failure-to-warn claims. Read my Law360 Expert Analysis of the Third Circuit’s August 15, 2024 decision in Schaffner v. Monsanto.

Third Circuit Roundup® Ruling Is Roadmap For Preemption Of Failure-To-Warn Claims Read More »

U.S. Judicial Conference’s Proposed Amicus Brief Amendments Are Unfriendly To The Civil Defense Bar

All Publications, Amicus Strategy & Procedure, Commentary, Federal Courts of Appeals, Published Articles /

FDCC’s “Friday 5” newsletter for August 30 includes my article discussing why the U.S. Judicial Conference’s Proposed Amicus Brief Amendments Are Unfriendly To The Civil Defense Bar. The article explains that the pending proposal to amend Federal Rule of Appellate Procedure 29 would require all non-governmental amicus briefs submitted to federal courts of appeals to

U.S. Judicial Conference’s Proposed Amicus Brief Amendments Are Unfriendly To The Civil Defense Bar Read More »

ALF Amicus Brief Supports Constitutional Challenge To Medicare “Drug Price Negotiation Program”

ALF Amicus Briefs, All Amicus Briefs, Federal Courts of Appeals /

The Inflation Reduction Act’s highly politicized, misleadingly named, “Drug Price Negotiation Program” is a form of government-imposed price control. Under the Program, the Centers for Medicare & Medicaid Services selects certain “negotiation-eligible” brand-name drugs. Following a supposed “negotiation” and “agreement” with its manufacturer, each such drug can be sold within the enormous Medicare/Medicaid system only

ALF Amicus Brief Supports Constitutional Challenge To Medicare “Drug Price Negotiation Program” Read More »

Ebner Quoted On U.S. Judicial Conference Amicus Rule Proposal

Amicus Strategy & Procedure, Appellate Practice, Commentary, Federal Courts of Appeals /

On June 4, 2024 the U.S. Judicial Conference’s Committee on Rules of Practice and Procedure decided to solicit public comment on proposed amendments to Federal Rule of Appellate Procedure 29 concerning the filing of amicus curiae briefs in federal courts of appeals. The amendments in part would require all court of appeals amicus briefs to

Ebner Quoted On U.S. Judicial Conference Amicus Rule Proposal Read More »

amicus brief commentary

Requiring Leave To File Amicus Briefs Is A Bad Idea

All Publications, Amicus Strategy & Procedure, Appellate Practice, Commentary, Federal Courts of Appeals, Published Articles /

The U.S. Judicial Conference’s Advisory Committee on Appellate Rules is considering a proposal to amend Federal Rule of Appellate Procedure 29(a) by requiring that a motion for leave be filed with all non-governmental amicus briefs in federal courts of appeals. In other words, if the proposed amendment were adopted, obtaining the parties’ consent to the

Requiring Leave To File Amicus Briefs Is A Bad Idea Read More »

Amicus Briefs Do Not Require Disqualification Of Supreme Court Justices

Amicus Strategy & Procedure, Commentary, DRI, Federal Courts of Appeals, US Supreme Court /

On November 13, 2023, the Justices of the Supreme Court of the United States issued a self-enforcing Code of Conduct applicable to themselves. The Code of Conduct section titled Disqualification includes the following statement: “Neither the filing of a brief amicus curiae nor the participation ofcounsel for amicus curiae requires a Justice’s disqualification” This statement

Amicus Briefs Do Not Require Disqualification Of Supreme Court Justices Read More »

Scroll to Top